Article
Mutant ATRX: uncovering a new therapeutic target for glioma.
Expert opinion on therapeutic targets - 1 Jul 2018
Haase Santiago, Garcia-Fabiani María Belén, Carney Stephen, Altshuler David, Núñez Felipe J, Méndez Flor M, Núñez Fernando, Lowenstein Pedro R, Castro Maria G
Abstract excerpt
INTRODUCTION: ATRX is a chromatin remodeling protein whose main function is the deposition of the histone variant H3.3. ATRX mutations are widely distributed in glioma, and correlate with alternative lengthening of telomeres (ALT) development, but they also affect other cellular functions related to epigenetic regulation. Areas covered: We discuss the main molecular characteristics of ATRX, from its various...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
